Literature DB >> 10423015

Calcitonin receptor antibodies in the identification of osteoclasts.

J M Quinn1, M Morfis, M H Lam, J Elliott, V Kartsogiannis, E D Williams, M T Gillespie, T J Martin, P M Sexton.   

Abstract

Osteoclasts are the cells responsible for bone resorption, and their number and rate of formation are critical in determining bone mass. To identify and quantify osteoclasts, as well as to study their formation in bone and in osteoclastogenic cultures, osteoclast-specific cell markers are required. Only the calcitonin receptor (CTR) expression unambiguously identifies osteoclasts and distinguishes them from macrophage polykaryons. However, present autoradiographic methods for CTR detection are cumbersome and time consuming. We have developed rabbit polyclonal antibodies specific for the C-terminal intracellular domain of the mouse and rat Cla CTR. These antibodies labeled HEK-293 cells stably transfected with CTR (but not untransfected HEK-293 cells). This labeling is abrogated by preabsorbing the antibodies with the recombinant antigen. The antibodies immunostained primary mouse and rat osteoclasts as well as osteoclasts in sections of mouse bone. Osteoclasts (both mononuclear and multinucleated) formed from mouse bone marrow or spleen cells cocultured with osteoblasts in the presence of 1,25 dihydroxyvitamin D3 and prostaglandin E2 were also specifically immunostained by the CTR antibodies. Cocultures incubated under conditions that did not allow osteoclastogenesis (i.e., omission of mediators or osteoblasts, or culture for less than 4 days) were not immunostained by CTR antibodies. Autoradiographic detection of 125I-labeled salmon calcitonin combined with CTR immunohistochemistry showed that both methods labeled the same cells. A CTR polyclonal antibody and monoclonal antibody F4/80 were used in combination to show immunofluorescence labeling of murine osteoclasts and macrophage populations, respectively, in marrow/osteoblast cocultures. These results indicate that simple and rapid CTR antibody-based methods can be used to identify osteoclasts, and can be used to characterize the antigenic profile of osteoclasts by using double immunofluorescence analysis.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10423015     DOI: 10.1016/s8756-3282(99)00094-0

Source DB:  PubMed          Journal:  Bone        ISSN: 1873-2763            Impact factor:   4.398


  26 in total

1.  Gene expression of osteoprotegerin ligand, osteoprotegerin, and receptor activator of NF-kappaB in giant cell tumor of bone: possible involvement in tumor cell-induced osteoclast-like cell formation.

Authors:  L Huang; J Xu; D J Wood; M H Zheng
Journal:  Am J Pathol       Date:  2000-03       Impact factor: 4.307

Review 2.  Role of osteoclasts in regulating hematopoietic stem and progenitor cells.

Authors:  Takeshi Miyamoto
Journal:  World J Orthop       Date:  2013-10-18

3.  Germline deletion of AMP-activated protein kinase beta subunits reduces bone mass without altering osteoclast differentiation or function.

Authors:  Julian M W Quinn; Shanna Tam; Natalie A Sims; Hasnawati Saleh; Narelle E McGregor; Ingrid J Poulton; John W Scott; Matthew T Gillespie; Bruce E Kemp; B J W van Denderen
Journal:  FASEB J       Date:  2009-09-01       Impact factor: 5.191

4.  Functional results of vertebral augmentation techniques in pathological vertebral fractures of myelomatous patients.

Authors:  Kamil Cagri Köse; Oguz Cebesoy; Burak Akan; Levent Altinel; Derya Dinçer; Tarik Yazar
Journal:  J Natl Med Assoc       Date:  2006-10       Impact factor: 1.798

5.  Activated macrophages for treating skin ulceration: gene expression in human monocytes after hypo-osmotic shock.

Authors:  O Frenkel; E Shani; I Ben-Bassat; F Brok-Simoni; G Rozenfeld-Granot; G Kajakaro; G Rechavi; N Amariglio; E Shinar; D Danon
Journal:  Clin Exp Immunol       Date:  2002-04       Impact factor: 4.330

6.  Amyloid β (Aβ) peptide directly activates amylin-3 receptor subtype by triggering multiple intracellular signaling pathways.

Authors:  Wen Fu; Araya Ruangkittisakul; David MacTavish; Jenny Y Shi; Klaus Ballanyi; Jack H Jhamandas
Journal:  J Biol Chem       Date:  2012-04-12       Impact factor: 5.157

7.  RANKL, OPG and CTR mRNA expression in the temporomandibular joint in rheumatoid arthritis.

Authors:  Wei-Wei Liu; Zhi-Min Xu; Zheng-Qiang Li; Yan Zhang; Bing Han
Journal:  Exp Ther Med       Date:  2015-07-08       Impact factor: 2.447

8.  Foreign body-type multinucleated giant cells induced by interleukin-4 express select lymphocyte co-stimulatory molecules and are phenotypically distinct from osteoclasts and dendritic cells.

Authors:  Amy K McNally; James M Anderson
Journal:  Exp Mol Pathol       Date:  2011-07-23       Impact factor: 3.362

9.  The elevated expression of calcitonin receptor by cells recruited into the endothelial layer and neo-intima of atherosclerotic plaque.

Authors:  Peter J Wookey; Anthony Zulli; David L Hare
Journal:  Histochem Cell Biol       Date:  2009-04-29       Impact factor: 4.304

10.  The proliferative human monocyte subpopulation contains osteoclast precursors.

Authors:  Roya Lari; Peter D Kitchener; John A Hamilton
Journal:  Arthritis Res Ther       Date:  2009-02-17       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.